Joseph S. Zakrzewski - 06 Feb 2024 Form 4 Insider Report for Cyteir Therapeutics, Inc.

Role: Director
Signature: /s/ David Gaiero, as attorney-in-fact for Joseph S. Zakrzewski
Issuer symbol: N/A
Transactions as of: 06 Feb 2024
Net transactions value: +$23,914
Form type: 4
Filing time: 08 Feb 2024, 16:11:10 UTC
Previous filing: 19 Jan 2024
Next filing: 21 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYT	Common Stock	Options Exercise	$23,914	+14,150	+6.6%	$1.69	227,439	06 Feb 2024	Direct
holding	CYT	Common Stock						149,051	06 Feb 2024	See Footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYT	Stock Option (Right to Buy)	Options Exercise	$0	-14,150	-100%	$0.000000^*	0	06 Feb 2024	Common Stock	14,150	$1.69	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by Z3 Trust, of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.